Defining the Substrate Specificity Determinants Recognized by the Active Site of C-Terminal Src Kinase-Homologous Kinase (CHK) and Identification of β-Synuclein as a Potential CHK Physiological Substrate
- 23 June 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 50 (31) , 6667-6677
Abstract
C-Terminal Src kinase-homologous kinase (CHK) exerts its tumor suppressor function by phosphorylating the C-terminal regulatory tyrosine of the Src-family kinases (SFKs). The phosphorylation suppresses their activity and oncogenic action. In addition to phosphorylating SFKs, CHK also performs non-SFK-related functions by phosphorylating other cellular protein substrates. To define these non-SFK-related functions of CHK, we used the “kinase substrate tracking and elucidation” method to search for its potential physiological substrates in rat brain cytosol. Our search revealed β-synuclein as a potential CHK substrate, and Y127 in β-synuclein as the preferential phosphorylation site. Using peptides derived from β-synuclein and positional scanning combinatorial peptide library screening, we defined the optimal substrate phosphorylation sequence recognized by the CHK active site to be E-x-[Φ/E/D]-Y-Φ-x-Φ, where Φ and x represent hydrophobic residues and any residue, respectively. Besides β-synuclein, cellular proteins containing motifs resembling this sequence are potential CHK substrates. Intriguingly, the CHK-optimal substrate phosphorylation sequence bears little resemblance to the C-terminal tail sequence of SFKs, indicating that interactions between the CHK active site and the local determinants near the C-terminal regulatory tyrosine of SFKs play only a minor role in governing specific phosphorylation of SFKs by CHK. Our results imply that recognition of SFKs by CHK is mainly governed by interactions between motifs located distally from the active site of CHK and determinants spatially separate from the C-terminal regulatory tyrosine in SFKs. Thus, besides assisting in the identification of potential CHK physiological substrates, our findings shed new light on how CHK recognizes SFKs and other protein substrates.Keywords
This publication has 34 references indexed in Scilit:
- A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brainNature Communications, 2010
- Deciphering Protein Kinase Specificity Through Large-Scale Analysis of Yeast Phosphorylation Site MotifsScience Signaling, 2010
- Structural recognition of an optimized substrate for the ephrin family of receptor tyrosine kinasesThe FEBS Journal, 2009
- Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of α-Synuclein in a pH-Dependent MannerJournal of Molecular Biology, 2009
- Structural insights into the inhibited states of the Mer receptor tyrosine kinaseJournal of Structural Biology, 2009
- Structural Basis for the Recognition of c-Src by Its Inactivator CskCell, 2008
- Mechanisms of specificity in protein phosphorylationNature Reviews Molecular Cell Biology, 2007
- LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activityBiochemical Journal, 2007
- Probability-based protein identification by searching sequence databases using mass spectrometry dataElectrophoresis, 1999
- Analysis of CSK Homologous Kinase (CHK/HYL) in Hematopoiesis by Utilizing Gene Knockout MiceBiochemical and Biophysical Research Communications, 1996